期刊文献+

丁酸氯维地平的细菌内毒素检查法 被引量:14

Bacterial Endotoxin Test for Clevidipine Butyrate
原文传递
导出
摘要 目的建立丁酸氯维地平的细菌内毒素检查方法。方法以60%乙醇溶液溶解丁酸氯维地平,再用细菌内毒素检查用水稀释后按中国药典2010年版二部附录细菌内毒素检查法,采用2个不同厂家的鲎试剂进行干扰试验。结果根据临床实际应用情况,确定丁酸氯维地平的内毒素限值L=4.7EU·mg-1;在本实验条件下,丁酸氯维地平的最大不干扰浓度为0.0133mg·mL-1,可用灵敏度0.06EU·mL-1及以上的鲎试剂检测丁酸氯维地平中的细菌内毒素。结论本试验建立的细菌内毒素检查方法可用于丁酸氯维地平的细菌内毒素检查,控制其产品质量。 OBJECTIVE To establish bacterial endotoxin test method for clevidipine butyrate. METHODS Clevidipine butyrate was dissolved with 60% ethanol and then diluted by water for bacterial endotoxin test. The experiment was carried out according to the bacterial endotoxin test method indexed in the appendix of Ch.P 2010 Vol II. Tachypleus amebocyte lysate from two manufacturers were used for interference test, RESULTS According to the dose of clinical medication, the most suitable limit of bacterial endotoxin in preparations for clevidipine butyrate was 4.7 EU.mg-1. Under this experimental condition, the maximum noninterference concentration for clevidipine butyrate was 0.013 3 mg-mL-1. It was effective that bacterial endotoxin was tested by tachypleus amebocyte lysate with the sensitivity of 0.06 EU.mL-1 or higher sensitivity. CONCLUSION This method can be used in bacterial endotoxin test of clevidipine butyrate and can be applied to control its quality.
出处 《中国现代应用药学》 CAS CSCD 2013年第9期1004-1008,共5页 Chinese Journal of Modern Applied Pharmacy
基金 安徽省食品药品监管系统科研项目(0004)
关键词 丁酸氯维地平 细菌内毒素 干扰试验 clevidipine butyrate bacterial endotoxin interference test
  • 相关文献

参考文献4

二级参考文献32

  • 1张德波,蒲旭峰,杨奎.奥沙利铂注射制剂细菌内毒素检查法研究[J].中国现代应用药学,2004,21(6):487-490. 被引量:3
  • 2张德波,蒲旭峰,杨幼琪.紫杉醇注射液细菌内毒素检查法研究[J].中国药品标准,2006,7(6):23-27. 被引量:2
  • 3聂颖兰,傅得兴,胡欣,王唯红.新型抗白血病药氯法拉滨[J].中国新药杂志,2007,16(10):821-824. 被引量:9
  • 4陈新谦 金有豫.新编药物学[M].北京:人民卫生出版社,1997.535.
  • 5ARONSON S, BOISVERT D, LAPP W. Isolated systolic hypertension is associated with adverse outcomes from coronary artery bypass grafting surgery[ J]. Anesth Analg, 2002,94(5 ) :1079 - 1084.
  • 6WEITZ HH. Perioperative cardiac complications [ J ]. Med Clin North Am, 2001,85(5) :1151 - 1169.
  • 7ERSTAD BL, BARLETTA JF. Treatment of hypertension in the perioperative patient [ J ]. Ann Pharmacother, 2000,34 ( 1 ) :66 - 79.
  • 8LESLIE JB. Incidence and aetiology of perioperative hypertension [ J ]. Acta Anaesthesiol Scand Suppl, 1993,37 ( 99 ) :5 - 9.
  • 9WEISS SJ, LONGNECKER DE. Perioperative hypertension: an overview[J]. Coron Artery Dis, 1993,4(5) :401 -406.
  • 10ESTAFANOUS FG, TARAZI RC. Systemic arterial hypertension associated with cardiac surgery [ J ]. Am J Cardlol, 1980,46 (4) :685 -694.

共引文献20

同被引文献116

  • 1王晓蕾,吕晓川,白林,高翠萍.鲎试剂检查注射用美洛西林钠/舒巴坦钠细菌内毒素的探讨[J].中华医院感染学杂志,2004,14(7):836-838. 被引量:1
  • 2刘宇,叶吉明,冉忠梅,赵刚.甘精胰岛素的临床应用[J].中国误诊学杂志,2006,6(5):825-827. 被引量:4
  • 3邱树胜,张铭穷.鲎实验检查盐酸丁卡因注射液细菌内毒素[J].海峡药学,2007,19(11):57-58. 被引量:3
  • 4Ch.P(2010)Vol Ⅱ(中国药典2010年版. 二部) [S]. 2010: Appendix 48.
  • 5Ch.P(2010) Vol II(中国药典 2010 年版.二部)[S]. 2010:638.
  • 6DALL L, HERNDON B. Quantitative assay of glycocalyxproduced by viridans group streptococci that causeendocarditis [J]. J Clin Microbiol, 1989, 27(9): 2039-2041.
  • 7MA L, ZHANG S, WANG A H, et al. Analysis on frequentissues of quantitative detection of bacterial endotoxin [J].中国医院药学杂志,2013, 33(9): 733-734.
  • 8XIAO G N, CHENG Z H, CHEN H A. Progress in detectiontechnology of pyrogen in drugs [J].中国药房,2009,20(19): 1507-1508.
  • 9MOHANAN P V, BANERJEE S,GEETHA C S. Detection ofpyrogenicity on medical grade polymer materials using rabbitpyrogen, LAL and ELISA method [J]. J Pharm Biomed Anal,2011,55(5): 1170-1174.
  • 10CLARK B E, AUYEUNG K, FREGOLINO E, et al. Abacterial lipooligosaccharide that naturally mimics the epitopeof the HIV-neutralizing antibody 2G12 as a template forvaccine design [J]. Chem Biol, 2012,19(2): 254-263.

引证文献14

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部